Three Seasons Wealth’s Novavax NVAX Stock Holding History

Three Seasons Wealth’s Portfolio NVAX Stock Details NVAX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q3	–	Sell	-11,287	Closed	-$143K	–	112
2024 Q2	$143K	Buy	+11,287	New	+$114K	0.08%	85

Other funds holding NVAX

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

SCM

Shah Capital Management Raleigh, North Carolina $521M AUM 46.95% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Bank of Montreal Toronto, Ontario, Canada $269B AUM 31.4% 1-Year Est. Return

Coatue Management New York $29.1B AUM 96.54% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Two Sigma Advisers New York $51.4B AUM 31.07% 1-Year Est. Return

Three Seasons Wealth's NVAX Position: Q3 2024 in Review

Three Seasons Wealth sold out of Novavax (NVAX) in Q3 2024, closing a stake of 11,287 shares — an estimated $143K sold.

Three Seasons Wealth first reported a position in NVAX in Q2 2024 and held it in 1 quarter. The position peaked at $143K in Q2 2024. 237 funds tracked by Wall St. Rank hold NVAX as of Q3 2024.

Three Seasons Wealth reported no remaining Novavax position as of Q3 2024 after selling out during the quarter.
Three Seasons Wealth sold 11,287 Novavax shares in Q3 2024, an estimated $143K.
Three Seasons Wealth first reported a position in Novavax in Q2 2024 and held it in 1 quarter.
Three Seasons Wealth's Novavax position peaked at $143K in Q2 2024.
237 funds tracked by Wall St. Rank held Novavax as of Q3 2024.

Based on Three Seasons Wealth's 13F filing for Q3 2024, filed 4 Apr 2025.